Owl Therapeutics
Owl Therapeutics is a biotechnology company focused on developing novel therapeutics to enhance microglia function for brain health. They leverage generative AI and biomarker-powered approaches to protect and restore the brain by improving the ability of microglia, the brain's immune cells, to clear harmful pathogens and debris. Their pipeline targets unmet patient needs in conditions exacerbated by aging, infection, injury, and disease, with a specific focus on traumatic brain injury (TBI) and Alzheimer's disease (AD). The company's leadership team comprises experienced drug developers, scientists, and clinicians.
Owl Therapeutics
Owl Therapeutics is a biotechnology company focused on developing novel therapeutics to enhance microglia function for brain health. They leverage generative AI and biomarker-powered approaches to protect and restore the brain by improving the ability of microglia, the brain's immune cells, to clear harmful pathogens and debris. Their pipeline targets unmet patient needs in conditions exacerbated by aging, infection, injury, and disease, with a specific focus on traumatic brain injury (TBI) and Alzheimer's disease (AD). The company's leadership team comprises experienced drug developers, scientists, and clinicians.